Cannabis use may lead to thinning of the cerebral cortex in adolescents according to a recent study led by Graciela Piñeyro and Tomáš Paus, researchers at CHU Sainte-Justine and professors at the Université de Montréal Faculty of Medicine. A collaborative effort between two research laboratories with complementary approaches, the study demonstrates that THC — or tetrahydrocannabinol, an active substance in cannabis — causes shrinkage of the dendritic arborization, neurons’ “network of antennae” whose role is critical for communication between neurons. This results in the atrophy of certain regions of the cerebral cortex — bad news at an age when the brain is maturing.

“If we take the analogy of the brain as a computer, the neurons would be the central processor, receiving all information via the synapses through the dendritic network,” explains Tomáš Paus, who is also a professor of psychiatry and neuroscience at Université de Montréal. “So a decrease in the data input to the central processor by dendrites makes it harder for the brain to learn new things, interact with people, cope with new situations, etc. In other words, it makes the brain more vulnerable to everything that can happen in a young person’s life.”

A multi-level approach to better understand the effect on humans

This project is notable for the complementary, multi-level nature of the methods used. “By analyzing magnetic resonance imaging (MRI) scans of the brains of a cohort of teenagers, we had already shown that young people who used cannabis before the age of 16 had a thinner cerebral cortex,” explains Tomáš Paus. “However, this research method doesn’t allow us to draw any conclusions about causality, or to really understand THC’s effect on the brain cells.”

Given the limitations of MRI, the introduction of the mouse model by Graciela Piñeyro’s team was key. “The model made it possible to demonstrate that THC modifies the expression of certain genes affecting the structure and function of synapses and dendrites,” explains Graciela Piñeyro, who is also a professor in the Department of Pharmacology and Physiology at Université de Montréal. “The result is atrophy of the dendritic arborescence that could contribute to the thinning observed in certain regions of the cortex.”

Interestingly, these genes were also found in humans, particularly in the thinner cortical regions of the cohort adolescents who experimented with cannabis. By combining their distinct research methods, the two teams were thus able to determine with a high degree of certainty that the genes targeted by THC in the mouse model were also associated to the cortical thinning observed in adolescents.

With cannabis use on the rise among North American youth, and commercial cannabis products containing increasing concentrations of THC, it’s imperative that we improve our understanding of how this substance affects brain maturation and cognition. This successful collaborative study, involving cutting-edge techniques in cellular and molecular biology, imaging and bioinformatics analysis, is a step in the right direction for the development of effective public health measures.

About the study

The article “Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence” was published by Xavier Navarri, Graciela Piñeyro and Tomáš Paus in the Journal of Neuroscience on October 6, 2024.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Treatment advances, predictive biomarkers stand to improve bladder cancer care

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial published in theNew England

Planning a drug’s route in the body with synthetic chemistry

Researchers at the RIKEN Cluster for Pioneering Research (CPR) have developed technology that can alter, within the body, the recognized identity of proteins. The innovation, published in Nature Communications on

New combination treatment brings hope to patients with advanced bladder cancer

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer. The results, which